U.S. FDA approved BioMarin’s ROCTAVIAN, the first and only gene therapy for adults with severe hemophilia A
On Jun. 29, 2023, the U.S. Food and Drug Administration approved Roctavian, an adeno-associated virus vector-based gene therapy…
On Jun. 29, 2023, the U.S. Food and Drug Administration approved Roctavian, an adeno-associated virus vector-based gene therapy…
On Jun. 27, 2023, researchers from Tel Aviv University announced they have developed an innovative gene therapy that…
On Jun. 27, 2023, the U.S. Centers for Disease Control and Prevention (CDC) adopted the 2023-2024 Advisory Committee…
On Jun. 26, 2023, the Centers for Disease Control and Prevention (CDC) announced they were collaborating with U.S….
On Jun. 26, 2023, Jaguar Health announced that the Take C.H.A.R.G.E. (Canine Health And ReGistry Exchange) had joined…
On Jun. 22, 2023 AquaBounty Technologies announced that the Company will pause the construction of its farm in…
On Jun. 22, 2023, the U.S. Food and Drug Administration (FDA) approved Sarepta Therapeutics’s Elevidys, the first gene…
On Jun. 22, 2023, the Institute for Health Metrics and Evaluation (IHME) reported that more than half a…
On Jun. 21, 2023, the World Health Organization announced that it had certified Belize as malaria-free, following the…
On Jun. 20, 2023, the U.S. Food and Drug Administration (FDA) approved Boehringer Ingelheim’s Jardiance (empagliflozin) and Synjardy…
On Jun. 17, 2023, the Mississippi man known as “Case 1,” the first person to be diagnosed with…
On Jun. 16, 2023, the U.S. Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory Committee…
On Jun. 6, 2023, President Biden announced the appointment of Dr. Mandy Cohen as Director of the Centers…
On Jun. 14, 2023, GOOD Meat, the cultivated meat division of food technology company Eat Just, Inc., announced…
On Jun. 6, 2023, the U.S. Food and Drug Administration (FDA) granted granted marketing authorization for the Cue COVID-19…
On Jun. 6, 2023, the University of Missouri College of Veterinary Medicine announced it had launched a rabies…
On Jun. 2, 2023, the Ministry of Health of the United Republic of Tanzania declared the end of…
On Jun. 1, 2023, two international teams announced they have sequenced the genomes of more than 200 nonhuman…
On Jun. 1, 2023, Illumina announced the new PrimateAI-3D, an artificial intelligence (AI) algorithm that predicts with unprecedented…
On Jun. 1, 2023, the National Institute of Allergy and Infectious Diseases and the National Cancer Institute reported…
Milestones in Parkinson’s illustrates advancements in the disease from James Parkinson’s essay on ‘shaking palsy’ to development of…
On May 31, 2023, the California Institute for Regenerative Medicine (CIRM) awarded $10 million to five facilities as…
On May 31, 2023, Pfizer announced that the U.S. Food and Drug Administration (FDA) had approved ABRYSVO (Respiratory…
On May 31, 2023, the World Health Organization announced it had assigned simple, easy to say and remember…
On May 30, 2023, the United Kingdom of Great Britain and Northern Ireland reported to the World Health…
On May 26, 2023, Novavax announced that Nuvaxovid (NVX-CoV2373) had been recommended for full Marketing Authorization (MA) for…
On May 25, 2023, the National Institutes of Health announced Initial findings from a study of nearly 10,000…
On May 25, 2023, the U.S. Food and Drug Administration (FDA) approved the oral antiviral Paxlovid (nirmatrelvir tablets…
On May 24, 2023, the U.S. Department of Agriculture (USDA) and the Department of Homeland Security (DHS) Science…
On May 24, 2023, the U.S. FDA approved Braeburn pharmaceutical’s Brixadi (buprenorphine) extended-release injection for subcutaneous use (under…